Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,426,085 papers from all fields of science
Search
Sign In
Create Free Account
Dyslipidemias
Known as:
Dyslipidemia
, Dyslipidemias [Disease/Finding]
Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Narrower (2)
Dyslipoproteinemias
Hooft disease
Hypercholesterolemia
In Blood
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Antipsychotics-induced metabolic alterations: Focus on adipose tissue and molecular mechanisms
P. Gonçalves
,
J. Araújo
,
F. Martel
European Neuropsychopharmacology
2015
Corpus ID: 25256024
Highly Cited
2010
Highly Cited
2010
Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2).
Shashank S Shah
,
Jayashree S. Todkar
,
P. Shah
,
D. Cummings
Surgery for Obesity and Related Diseases
2010
Corpus ID: 26018720
Review
2009
Review
2009
The possible role of lipocalin-2, retinol binding protein-4, and adiponectin
E. Esteve
,
W. Ricart
2009
Corpus ID: 207885620
I t is well known that adipocytes and resident macrophages that have migrated to adipose tissue produce and secrete a variety of…
Expand
Highly Cited
2006
Highly Cited
2006
Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications.
L. Clavijo
,
T. L. Pinto
,
+7 authors
R. Waksman
Cardiovascular Revascularization Medicine
2006
Corpus ID: 30138532
Review
2004
Review
2004
Animal models of nonalcoholic fatty liver disease and steatohepatitis.
A. Nanji
Clinical Liver Disease
2004
Corpus ID: 9622338
Highly Cited
2002
Highly Cited
2002
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while…
G. Etgen
,
B. A. Oldham
,
+18 authors
R. Kauffman
Diabetes
2002
Corpus ID: 29436592
A novel nonthiazolidinedione dual peroxisome proliferator- activated receptor (PPAR)-alpha/gamma agonist, LY465608, was designed…
Expand
Highly Cited
2002
Highly Cited
2002
Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease.
L. Christiaens
,
L. Macchi
,
+5 authors
A. Brizard
Thrombosis Research
2002
Corpus ID: 10158802
Review
1997
Review
1997
Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis.
H. Esterbauer
,
R. Schmidt
,
M. Hayn
Advances in Pharmacology
1997
Corpus ID: 44474770
Review
1996
Review
1996
The impact of ethnicity on response to antihypertensive therapy.
K. Jamerson
,
V. Dequattro
American Journal of Medicine
1996
Corpus ID: 21480298
Highly Cited
1995
Highly Cited
1995
Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects.
Bruce E. Wilson
,
Anita Gondy
Diabetes Research and Clinical Practice
1995
Corpus ID: 8394786
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE